Načítá se...
Using Clinical Trial Data to Tailor Adjuvant Treatments for Individual Patients
The 2005 St. Gallen Consensus Panel provided recommendations for the treatment of early breast cancer which rely on target identification first. The foremost advance since 2005— demonstration of trastuzumab efficacy for patients with HER2-positive disease—was realized because an effective treatment...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2723737/ https://ncbi.nlm.nih.gov/pubmed/17719227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2007.07.016 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|